申请人:Ruebsam Frank
公开号:US20090306057A1
公开(公告)日:2009-12-10
The invention is directed to [1,2,4]thiadiazine 1,1-dioxide compounds and pharmaceutical compositions containing such compounds that are useful in treating infections by hepatitis C virus.
这项发明涉及[1,2,4]噻二嗪1,1-二氧化物化合物和含有这种化合物的药物组合物,可用于治疗丙型肝炎病毒感染。